@article{86b659f34f204c5e926e723223ae6ebd,
title = "Reply to Kao & Gau {\textquoteleft}Comedications, underlying comordity status, and its influence on inflammatory status and depression risk.{\textquoteright}",
author = "Rachel Latham and Helen Fisher",
note = "Funding Information: The E-Risk Study is funded by the Medical Research Council (UK MRC) [G1002190]. Additional support was provided by the U.S National Institute of Child Health and Human Development (NICHD) [HD077482]; the Jacobs Foundation; the King{\textquoteright}s Together Multi and Interdisciplinary Research Scheme (Wellcome Trust Institutional Strategic Support Fund; grant 204823/Z/16/Z); MQ Transforming Mental Health Charity, Brighter Futures grant named “Identifying Depression Early in Adolescence” [MQBF/1 IDEA]; plus the UK MRC [MC_PC_MR/R019460/1] and the Academy of Medical Sciences [GCRFNG\100281] under the Global Challenges Research Fund. Helen L. Fisher and Rachel M. Latham are supported by the Economic and Social Research Council (ESRC) Centre for Society and Mental Health at King{\textquoteright}s College London [ES/S012567/1]. The views expressed are those of the authors and not necessarily those of the ESRC or King{\textquoteright}s College London. These funders played no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; nor in the decision to submit this article for publication.",
year = "2022",
month = aug,
doi = "10.1016/j.bbi.2022.04.021",
language = "English",
volume = "104",
pages = "220--221",
journal = "Brain Behavior and Immunity",
issn = "0889-1591",
publisher = "ACADEMIC PRESS INC",
}